RAD-140 Capsules
$79.99
In stockRAD-140, commonly known as Testolone, is an investigational, nonsteroidal selective androgen receptor modulator (SARM). It activates androgen receptors involved in processes such as muscle growth and tissue maintenance. Researchers developed it to investigate whether anabolic activity could be directed preferentially toward certain tissues.
| SKU | RC-RR-RAD140-60CT |
|---|---|
| Manufacturer | R+R Innovations |
| Form | Capsule |
| Strength | 15 mg |
| Size | 60 count |
| Reported Result | Supplier spec pending verification |
| Stock | In stock |
| Documentation Status | Pending Final COA |
Product Description
RAD-140, commonly known as Testolone, is an investigational, nonsteroidal selective androgen receptor modulator (SARM). It activates androgen receptors involved in processes such as muscle growth and tissue maintenance. Researchers developed it to investigate whether anabolic activity could be directed preferentially toward certain tissues. “Selective” does not mean that its effects are limited to muscle or that it is free of systemic risks.
What research has shown:
Anabolic activity in animal models: Preclinical experiments demonstrated increased muscle weight in rats, with muscle responses occurring at lower exposures than those needed to produce comparable prostate stimulation. These findings support tissue selectivity in those models rather than proven safety or effectiveness in people.
Preliminary body-composition findings: A small monkey study reported increased body weight and a trend toward increased lean tissue.
Androgen-receptor activity in humans: A phase I trial involving 22 women with advanced breast cancer demonstrated biological evidence of androgen-receptor engagement and preliminary antitumor activity. This specialized cancer study did not evaluate bodybuilding, strength, or exercise recovery.
Important safety findings: The human trial frequently reported elevated liver enzymes and bilirubin. Separately, published case reports describe severe liver injury following use of products identified as RAD-140.
Storage and handling: Keep sealed, dry, and protected from heat and direct light unless the final product label or COA states otherwise. Maintain the product with its matching batch record.
Third-party testing status.
| Batch / Lot | Reported Result | Tested | Partner | Status | Document |
|---|---|---|---|---|---|
| N/A | 98.16%+0.18% | Jun 25, 2026 | Vanguard Laboratory | Complete | View COA |
.png)